Is it safe to treat allogeneic stem cell transplant recipients at home during the pancytopenic phase? A pilot trial. - Wikidata - awgldk - TriplyDB

Is it safe to treat allogeneic stem cell transplant recipients at home during the pancytopenic phase? A pilot trial.

Is it safe to treat allogeneic stem cell transplant recipients at home during the pancytopenic phase? A pilot trial.

http://www.wikidata.org/entity/Q40611081

about

Patients' experiences of different care settings and a new life situation after allogeneic haematopoietic stem cell transplantation.A scoping review of caregiver burden during allogeneic HSCT: lessons learned and future directions.Family members' life situation and experiences of different caring organisations during allogeneic haematopoietic stem cells transplantation-A qualitative study.Home care during neutropenia after allogeneic hematopoietic stem cell transplantation in children and adolescents is safe and may be more advantageous than isolation in hospital.General health, symptom occurrence, and self-efficacy in adult survivors after allogeneic hematopoietic stem cell transplantation: a cross-sectional comparison between hospital care and home care.Symptom experience of multiple myeloma (syMMex) patients treated with autologous stem cell transplantation following high-dose melphalan: a descriptive longitudinal study.Long-term outcome in patients treated at home during the pancytopenic phase after allogeneic haematopoietic stem cell transplantation.Long-term follow-up of patients treated at home during the pancytopenic phase after allogeneic haematopoietic stem cell transplantation.

P2860

Q38751585-389D7BA0-C29B-4FBC-8EFA-332282388CAD Q38801133-5B831C28-CA72-4735-BDA0-D1CE1D8E153A Q39176991-BA04B2ED-2FE7-42D0-849F-E00C36AF544E Q43486658-74FF4C01-1598-4E19-93FE-6D79EC5039F5 Q43988469-3E27B3B2-A43E-4CDB-AE28-1D1E0E91BFE3 Q47636780-F9716FA3-F86D-446F-BE58-6E197B0D54C0 Q48295098-C4372A5E-C2F8-4C1A-B40A-3AAD53BB1A90 Q53665940-A32E2B23-DD60-4C9F-87F8-A5F21ADE3713

P2860

Is it safe to treat allogeneic stem cell transplant recipients at home during the pancytopenic phase? A pilot trial.

http://www.wikidata.org/entity/Q40611081

description

2000 nî lūn-bûn

@nan

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

2000年论文

@zh

2000年论文

@zh-cn

name

Is it safe to treat allogeneic ...... ytopenic phase? A pilot trial.

@en

type

label

Is it safe to treat allogeneic ...... ytopenic phase? A pilot trial.

@en

prefLabel

Is it safe to treat allogeneic ...... ytopenic phase? A pilot trial.

@en

P1433

Q40611081-1C926E95-AE68-44C6-B9D0-58CF6BBD1D78

P1476

Q40611081-D9E26257-F0BD-4FD5-866B-7593109468AE

P2093

Q40611081-37BAFFE7-E329-4D0F-B693-5EE02875C927

Q40611081-48784926-26EE-4927-BB2E-9E293EDD4FAA

Q40611081-8633A8DE-849F-4715-8AA4-782C6EFCC8E3

Q40611081-AEEA26D9-6E6B-4A03-9442-C35C48E96B18

Q40611081-DCD96758-949D-4825-95FF-21B3ED0652B2

P2860

Q40611081-02FFE097-1306-44F2-853E-207EB0BB3335

Q40611081-4C17C206-324F-418A-9E75-51F4FD30462F

Q40611081-7075CA1B-EB72-4AE2-9C40-27C4DE09A66E

Q40611081-9F2D020F-7604-49EA-A679-8B393266454B

Q40611081-BAE9CE47-46C6-4DBE-B980-EB4FCD5FACCC

Q40611081-CA37DCE6-B102-4943-80F1-DD0F9057E28F

Q40611081-D81360D5-66AD-49E7-AF26-3539431A996E

Q40611081-F0525590-2E7B-472B-91CB-24A41A0A0B99

Q40611081-F6455A54-555E-42CE-9ADE-0CD591BA3A1E

Q40611081-F6F262B8-F50E-46F0-AB5B-07D1E56DDD0A

P2888

Q40611081-B4054A48-2100-49B0-81C7-C46BBA0C00A2

P304

Q40611081-25C6EA00-8AC5-4E55-A814-762DCF7CF18B

P31

Q40611081-FD80B50E-5DF6-44C5-BBE7-A754EAD3C49F

P356

Q40611081-A58A16EC-7389-43A8-9441-914692ECA667

P407

Q40611081-A60A0F27-97F1-4D23-90C2-FC029E2C3A9C

P433

Q40611081-229D3472-B93F-4169-B106-B2DD30B967EF

P478

Q40611081-59076A2B-F71C-4DDD-9226-5DB1A8F8CBE8

P577

Q40611081-E9E29CD4-3E80-4B52-9ED5-A7ED6976A40C

P5875

Q40611081-7007DE60-7D58-4EDA-ADC9-997B49ECF2D1

P6179

Q40611081-D091CE80-F0B1-437C-A065-901322CB7BD8

P698

Q40611081-E1F9365E-960E-4164-A564-808C3E1DD63F

P356

P1433

Bone Marrow Transplantation

P1476

Is it safe to treat allogeneic ...... ytopenic phase? A pilot trial.

@en

P2093

Aschan J

http://www.w3.org/2001/XMLSchema#string

Bjurman B

http://www.w3.org/2001/XMLSchema#string

Myrbäck KE

http://www.w3.org/2001/XMLSchema#string

Ringdén O

http://www.w3.org/2001/XMLSchema#string

Svahn BM

http://www.w3.org/2001/XMLSchema#string

P2860

What is in store after stem-cell transplantation?

Protective environment for marrow transplant recipients: a prospective study.

Pulmonary aspergillosis in patients with leukaemia

Allogeneic bone marrow transplantation for hematological malignancies--controversies and recent advances.

Bacteraemia during the aplastic phase after allogeneic bone marrow transplantation is associated with early death from invasive fungal infection.

Allogeneic bone-marrow transplantation without protective isolation in adults with malignant disease.

Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia.

Low incidence of acute graft-versus-host disease, using unrelated HLA-A-, HLA-B-, and HLA-DR-compatible donors and conditioning, including anti-T-cell antibodies.

Impact of air filtration on nosocomial Aspergillus infections. Unique risk of bone marrow transplant recipients.

Influence of protective isolation on outcome of allogeneic bone marrow transplantation for leukemia.

P2888

P304

1057-1060

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BMT.1702672

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P577

2000-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12220421

http://www.w3.org/2001/XMLSchema#string

P6179

1017287983

http://www.w3.org/2001/XMLSchema#string

P698

11108303

http://www.w3.org/2001/XMLSchema#string